巴西政府紧急停止使用中国疫苗康西诺
China's CanSino cuts ties with Brazil firm, halting vaccine licensing 6park.com 6park.com 6park.comFILE PHOTO: China's vaccine specialist CanSino Biologics Inc in Tianjin 6park.com 6park.com 6park.com 6park.comTue, June 29, 2021, 10:16 AM 6park.comBRASILIA (Reuters) - Brazilian health regulator Anvisa has canceled a request for emergency use authorization for the COVID-19 vaccine developed by China's CanSino Biologics Inc after the laboratory cut ties with its Brazilian representative.
The move follows a wave of scrutiny in Brazil of vaccine contracts negotiated by intermediaries, a common local practice. 6park.com
|